Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer

BACKGROUND: Therapy with anti-epidermal growth factor receptor (egfr) monoclonal antibody improves outcomes for patients with metastatic colorectal cancer (mcrc) in the first-, second-, and third-line trial settings. In British Columbia, the use of egfr inhibitors (egfris) is confined to third-line...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Curr Oncol
Main Authors: Ho, M.Y., Renouf, D.J., Cheung, W.Y., Lim, H.J., Speers, C.H., Zhou, C., Kennecke, H.F.
Formáid: Artigo
Teanga:Inglês
Foilsithe: Multimed Inc. 2016
Ábhair:
Original Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5081009/
https://ncbi.nlm.nih.gov/pubmed/27803597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.23.3030
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla